Login To Trade  |  About IIFL
  • NIFTY  8484.9  40 0.47%
  • SENSEX 28092.79  146.99 0.53%
  1. News
  2. Sector

  3. Pharma & Healthcare

Covidien to buy Somanetics

India Infoline News Service | Mumbai | June 16, 2010 17:06 IST

The deal values Somanetics at a premium of US$6.10, or 32%, over its closing price of US$18.9 a share on 15th June.

Covidien Plc plans to buy Somanetics Corp. for US$25 a share in cash, according to reports. The deal valued at US$250mn. Covidien said the acquisition would broaden its medical equipment product offerings and create earnings growth over time. The deal values Somanetics at a premium of US$6.10, or 32%, over its closing price of US$18.9 a share on 15th June.






Read more on: Covidien  to  buy  Somanetics   
article
113101301220
Covidien to buy Somanetics
Covidien to buy Somanetics
The deal values Somanetics at a premium of US$6.10, or 32%, over its closing price of US$18.9 a share on 15th June.
http://www.indiainfoline.com/article/news-sector-pharma-healthcare/covidien-to-buy-somanetics-113101301220_1.html
June 16, 2010 17:06 IST
http://content.indiainfoline.com/_media/iifl/img/article/default/glo_news.jpg
Covidien to buy Somanetics
Pharma & Healthcare
$rawVideoFileUrl$
$videoPlayerUrl$
Recent Reports

Weak start to the July series; Sensex, Nifty to open lower

India Infoline Research Team / 08:44, Jun 26, 2015

IIFL is hosting 10 companies at a Management Roadshow in Mumbai today. The opening is a subdued start. US market saw minor losses with Dow, S&P 500 and Nasdaq closing marginally lower.

News